Trial · NCT00413634
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Maximum Plasma Concentration (Cmax) of Agrylin | over 1 day | PK population (defined as all patients with post-dose drug concentration data) | ng/ml | GEOMETRIC_MEAN |
| SECONDARY | Platelet Count | over 1 day | Safety population (defined as all patients who received study treatment) | x 1,000,000,000/L | MEAN |
| SECONDARY | Heart Rate | over 1 day | Safety population | beats/min | MEAN |
| PRIMARY | Time of Maximum Plasma Concentration (Tmax) of Agrylin | over 1 day | PK population | hours | GEOMETRIC_MEAN |
| PRIMARY | Area Under the Steady-state Plasma Concentration-time Curve (AUC) of Agrylin | over 1 day | PK population | ng.h/ml | GEOMETRIC_MEAN |
| PRIMARY | Terminal Half-life (T 1/2) of Agrylin | over 1 day | PK population | hours | GEOMETRIC_MEAN |
| PRIMARY | Total Clearance (CL/F) of Agrylin | over 1 day | PK population | L/h | GEOMETRIC_MEAN |
| PRIMARY | Volume of Distribution (Vz/F) of Agrylin | over 1 day | PK population | L | GEOMETRIC_MEAN |
| PRIMARY | Cmax of Active Metabolite | over 1 day | PK population | ng/ml | GEOMETRIC_MEAN |
| PRIMARY | Tmax of Active Metabolite | over 1 day | PK population | hours | GEOMETRIC_MEAN |
| PRIMARY | AUC of Active Metabolite | over 1 day | PK population | ng.h/ml | GEOMETRIC_MEAN |
| PRIMARY | T 1/2 of Active Metabolite | over 1 day | PK population | hours | GEOMETRIC_MEAN |
| PRIMARY | CL/F of Active Metabolite | over 1 day | PK population | L/h | GEOMETRIC_MEAN |
| PRIMARY | Vz/F of Active Metabolite | over 1 day | PK population | L | GEOMETRIC_MEAN |
| SECONDARY | Systolic Blood Pressure | over 1 day | Safety population | mmHg | MEAN |
| SECONDARY | Diastolic Blood Pressure | over 1 day | Safety population | mmHg | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00413634/outcomes